Exposing Discrepancies: Pfizer Whistleblower Reveals Separate COVID-19 Vaccine Batches for Employees

This disclosure adds to the mounting evidence suggesting that certain individuals received distinct COVID-19 vaccine formulations or even placebos compared to the general population.

It has come to light that a series of experiments were conducted on the global population under the guise of "vaccination" to protect from COVID-19. A whistleblower from Pfizer leaked an internal company email dated January 8, 2021, explicitly stating that the COVID-19 vaccines provided to Pfizer employees were distinct from those offered to the general public. The email, addressed to Pfizer employees and contractors at the Pearl River research site in Rockland County, New York, announced the commencement of COVID-19 vaccinations for eligible on-site essential colleagues and contractors.

The email's assurance that the vaccine doses for the employee program were “separate and distinct” from those committed by Pfizer to governments worldwide, and would not impact the supply to national governments, raises serious concerns. It hints at a potential dehumanization of individuals by the federal government, facilitating multiple vaccine experiments that could have unforeseen and harmful effects.

Check out the email below which was sent to “colleagues and contractors” at Pfizer’s Pearl River Site. Pay close attention to the bottom part that’s circled in yellow. “The vaccine doses to be used for this program are separate and distinct from those committed by Pfizer to governments around the world and will not impact supply to national governments in any way.”

Pfizer's Pearl River research site, situated in Rockland County, New York, is one of nine major research and development (R&D) hubs for Pfizer. According to the website, the Pearl River site is the primary center for research and development activities, particularly concerning Pfizer's collaboration with BioNTech on COVID-19 vaccines.

During an August session in the Australian Senate, a Pfizer representative revealed that company employees were provided with a "batch of vaccines specifically designated for the employee vaccination program.

Since the onset of stringent lockdown measures, individuals have been categorized as "essential" or "non-essential," with their rights subject to authoritarian decrees. As COVID-19 vaccines were rapidly rolled out, governments further segregated people into priority groups based on social status, facilitating experimentation with different vaccine batches at different times. This lack of transparency in the vaccine distribution process leaves the public in the dark and in need of more information.

Independent investigators have analyzed adverse event data reported by batch number in the Vaccine Adverse Events Reporting System (VAERS) and found variations in toxicity and lethality among different vaccine batches. This data fuels allegations of vaccine companies conducting batch experiments on the population under the guise of safe and effective COVID-19 vaccines.

The leaked Pfizer email revealed that a distinct batch of COVID-19 vaccines was reserved for employees categorized as "site-essential colleagues" at specific Pfizer locations. Employees were mandated to receive the vaccine at a Pfizer location to ensure the continuity of critical research and development programs.

In an interview with Infowars, the Pfizer whistleblower disclosed that employees were aware of receiving either a placebo or a different formula. This disclosure aligns with Pfizer representatives' testimony before the Australian government, confirming the company's provision of a specific batch of COVID-19 shots for its workers.

The revelation of a separate vaccine batch for Pfizer employees underscores the existence of varying risk profiles among vaccine batches. This raises urgent questions that demand answers. Further investigation is necessary to uncover the differences in these batches and the reasons behind Pfizer's decision to reserve a specific batch for its employees and contractors.